Billionaires Jeff Bezos and Bill Gates have invested in Neuralink’s competitor Synchron, a startup that develops brain-computer interfaces. The company’s device, designed to help the paralyzed, is already being tested on humans.
Synchron, which develops BCI systems, or “brain-computer”, announced the completion of a $75 million funding round, Bloomberg reports. Thus, the total amount of investments in the company amounted to $145 million, which, according to Pitchbook researchers, is less than that of the main competitors – Elon Musk’s Neuralink and Science Corp. Max Hodak.

According to the agency, ARCH Venture Partners invested most of the funds. Another part is the Bezos Expeditions company of Amazon founder Jeff Bezos. The list of investors also included the Gates Frontier venture investment company of Microsoft co-founder Bill Gates, as well as Khosla Ventures and other companies.